Decreased serum PON1 activities have been reported in several diseases that have an infectious or inflammatory component, including bacterial infections [15,16,17], and non-communicable diseases such as chronic liver diseases, cardiovascular diseases, and cancer [10,14]. This evidence concerns the gene PON1 and cancer.